Emcure Pharmaceuticals IPO Achieves 4.98x Subscription Rate on Day 2

Emcure Pharmaceuticals IPO saw varied interest on Day 2, with QIBs at 1.00x, NII at 13.67x, RII at 3.43x, and Employees at 4.83x, totaling a 4.98x subscription rate.
Emcure Pharmaceuticals IPO Achieves 4.98x Subscription Rate on Day 2

Emcure Pharmaceuticals IPO saw varied interest on Day 2, with subscriptions reaching 1.00 times for Qualified Institutional Buyers, 13.67 times for Non-Institutional Investors, 3.43 times for Retail Individual Investors, and 4.83 times for Employees, totaling a subscription rate of 4.98 times.

Investor CategorySubscription (times)Shares OfferedShares Bid For
QIB Investors1.0037,62,89637,50,040
HNIs / NIIs13.6729,49,5234,03,06,560
Retail Investors3.4368,82,2192,36,04,070
Employees4.83      1,08,9005,26,358
Total4.981,37,03,5386,81,87,028

Source: NSE

How To Check Emcure Pharmaceuticals Limited IPO Subscription Status?

Steps to check the IPO subscription status on NSE

Following are the steps to check it through the NSE website

  • Visit NSE‘s official website.
  • Navigate to the ‘Market Data’ tab.
  • Choose ‘IPO’.
  • Select the Emcure Pharmaceuticals Limited IPO to check its subscription status.
  • Opt for either NSE Bid details or Consolidated Bid details.
  • Explore the total number of bids received from various investors. 

Emcure Pharmaceuticals IPO Allotment Status

The allotment date for the Emcure Pharmaceuticals IPO is set for July 8, 2024, with shares priced at a range of ₹960 to ₹1008  per share and a face value of ₹ 10. The offering consists of lots of 14 shares, with bids accepted for these lots or their multiples. 

Emcure Pharmaceuticals Limited IPO Listing Date 

Emcure Pharmaceuticals IPO is expected to be listed on the NSE SME on July 10, 2024.

Loading
Read More News

STOP PAYING

₹ 20 BROKERAGE

ON TRADES !

Trade Intraday and Futures & Options